Learn more about whether Alvotech or Arrowhead Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor ...

Stocks in the Nordic region rose Tuesday, with the OMX Nordic 40 Index rising 1.5%. Orsted A/S was the biggest leader among large stocks during the session, jumping 14.5%, and Bravida Holding AB rose ...

Teva and Alvotech announced that the U.S. Food and Drug Administration (FDA) approved SELARSDI (ustekinumab-aekn) injection as ...

In the role of liquidity provider, DNB Carnegie undertakes to continuously quote prices for Alvotech's SDRs in accordance ...

Not to be released, published, distributed or circulated in any jurisdiction in which it would be unlawful to do so. This ...

REYKJAVIK, ICELAND AND STOCKHOLM, SWEDEN (May 8, 2025) - Alvotech (NASDAQ: ALVO, the "Company"), a global biotech company specializing in the development and manufacture of biosimilar medicines ...

A 2022 study in Nature Medicine showed that AI models could predict future fractures with greater accuracy than traditional ...

Not to be released, published, distributed or circulated in any jurisdiction in which it would be unlawful to do so. This ...

One of Iceland's largest companies, the pharmaceutical firm Alvotech, has announced its intention to list on Nasdaq Stockholm ...

Selardsdi is indicated for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adults and ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the BofA ...